Skip to main content
. 2010 Jul 27;4(7):e763. doi: 10.1371/journal.pntd.0000763

Figure 2. Location of the villages and levels of prevalence: low (A: 0–4%), intermediate (B: 5–14%) and high (C: >15%) RVFV antibody prevalence rates.

Figure 2